These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 22249132)
1. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma. Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132 [TBL] [Abstract][Full Text] [Related]
2. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance. Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867 [TBL] [Abstract][Full Text] [Related]
3. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma. Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031 [TBL] [Abstract][Full Text] [Related]
4. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma. Wang L; Gu F; Liu CY; Wang RJ; Li J; Xu JY Tumour Biol; 2013 Apr; 34(2):853-8. PubMed ID: 23242609 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402 [TBL] [Abstract][Full Text] [Related]
6. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116 [TBL] [Abstract][Full Text] [Related]
8. MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma. Chen DW; Fan YF; Li J; Jiang XX Tumour Biol; 2013 Jun; 34(3):1553-7. PubMed ID: 23400716 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Tbx3 predicts poor prognosis of patients with resectable pancreatic carcinoma. Wang HC; Meng QC; Shan ZZ; Yuan Z; Huang XY Asian Pac J Cancer Prev; 2015; 16(4):1397-401. PubMed ID: 25743805 [TBL] [Abstract][Full Text] [Related]
10. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001 [TBL] [Abstract][Full Text] [Related]
11. Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis. Zhao ZK; Wu WG; Chen L; Dong P; Gu J; Mu JS; Yang JH; Liu YB Tumour Biol; 2013 Jun; 34(3):1473-7. PubMed ID: 23355337 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer. Bronsert P; Kohler I; Timme S; Kiefer S; Werner M; Schilling O; Vashist Y; Makowiec F; Brabletz T; Hopt UT; Bausch D; Kulemann B; Keck T; Wellner UF Surgery; 2014 Jul; 156(1):97-108. PubMed ID: 24929761 [TBL] [Abstract][Full Text] [Related]
13. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504 [TBL] [Abstract][Full Text] [Related]
14. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma. Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801 [TBL] [Abstract][Full Text] [Related]
15. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance. Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944 [TBL] [Abstract][Full Text] [Related]
16. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)]. Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482 [TBL] [Abstract][Full Text] [Related]
17. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420 [TBL] [Abstract][Full Text] [Related]
18. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness. Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129 [TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas. Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777 [TBL] [Abstract][Full Text] [Related]
20. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]